Sonoma Pharmaceuticals appoints Controller and sets new interim CFO consulting terms

Sonoma Pharmaceuticals, Inc.

John Dal Poggetto appointed Controller effective July 17, 2023; annual salary $100,000, bonus up to 20%, option grant for 5,000 shares vesting over three years.
New consulting agreement with Jerome Dvonch Consulting, LLC at $20,000/month, effective August 15, 2023, with Dvonch continuing as interim CFO.
Dvonch's vested equity awards extended by one extra month per month of continued service, capped by current plan provisions.
Dal Poggetto will work part-time, reporting to interim CFO Dvonch; role is at-will with standard benefits and 3 weeks vacation.
No changes to other executive officers or board composition disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Dal Poggetto

Controller

SNOA · Sonoma Pharmaceuticals, Inc.

Effective: 2023-07-17
Filed: July 14, 2023, 7:59 PM ET

Effective July 17, 2023, our Board of Directors appointed John Dal Poggetto as our Controller.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

John Dal Poggetto was appointed as Controller at Sonoma Pharmaceuticals, Inc..

Action: appointed
Role: Controller

Exact text from the filing

Effective July 17, 2023, our Board of Directors appointed John Dal Poggetto as our Controller.

View on SEC.gov

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-004933

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.